Holmes Biopharma, Inc. (LMB) Reports Q2 EPS of $0.09, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/28/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. RKLB

Go back to Holmes Biopharma, Inc. (LMB) Reports Q2 EPS of $0.09, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus
Holmes Biopharma, Inc. (NASDAQ: LMB) Delayed: 81.26 -0.65 (0.79%)
Previous Close $81.91    52 Week High $0.15 
Open $81.29    52 Week Low $0.15 
Day High $84.00    P/E N/A 
Day Low $80.00    EPS $0.00 
Volume 386,377